131 related articles for article (PubMed ID: 9322954)
1. Regulation of osteoclastogenesis by antisense oligodeoxynucleotides specific to zinc finger nuclear transcription factors Egr-1 and WT1 in rat bone marrow culture system.
Kukita T; Kukita A; Harada H; Iijima T
Endocrinology; 1997 Oct; 138(10):4384-9. PubMed ID: 9322954
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-10 selectively inhibits osteoclastogenesis by inhibiting differentiation of osteoclast progenitors into preosteoclast-like cells in rat bone marrow culture system.
Xu LX; Kukita T; Kukita A; Otsuka T; Niho Y; Iijima T
J Cell Physiol; 1995 Dec; 165(3):624-9. PubMed ID: 7593242
[TBL] [Abstract][Full Text] [Related]
3. Suppression of v-sis-dependent transformation by the transcription factor, Egr-1.
Huang RP; Darland T; Okamura D; Mercola D; Adamson ED
Oncogene; 1994 May; 9(5):1367-77. PubMed ID: 8152797
[TBL] [Abstract][Full Text] [Related]
4. The zinc finger transcription factor Egr-1 is essential for and restricts differentiation along the macrophage lineage.
Nguyen HQ; Hoffman-Liebermann B; Liebermann DA
Cell; 1993 Jan; 72(2):197-209. PubMed ID: 7678779
[TBL] [Abstract][Full Text] [Related]
5. Osteoclast-derived zinc finger (OCZF) protein with POZ domain, a possible transcriptional repressor, is involved in osteoclastogenesis.
Kukita A; Kukita T; Ouchida M; Maeda H; Yatsuki H; Kohashi O
Blood; 1999 Sep; 94(6):1987-97. PubMed ID: 10477728
[TBL] [Abstract][Full Text] [Related]
6. EGR-1 enhances tumor growth and modulates the effect of the Wilms' tumor 1 gene products on tumorigenicity.
Scharnhorst V; Menke AL; Attema J; Haneveld JK; Riteco N; van Steenbrugge GJ; van der Eb AJ; Jochemsen AG
Oncogene; 2000 Feb; 19(6):791-800. PubMed ID: 10698497
[TBL] [Abstract][Full Text] [Related]
7. Extremely High Expression of Antisense RNA for Wilms' Tumor 1 in Active Osteoclasts: Suppression of Wilms' Tumor 1 Protein Expression during Osteoclastogenesis.
Li YJ; Kukita A; Kyumoto-Nakamura Y; Kukita T
Am J Pathol; 2016 Sep; 186(9):2317-25. PubMed ID: 27393793
[TBL] [Abstract][Full Text] [Related]
8. Catalytic antisense DNA molecules targeting Egr-1 inhibit neointima formation following permanent ligation of rat common carotid arteries.
Lowe HC; Chesterman CN; Khachigian LM
Thromb Haemost; 2002 Jan; 87(1):134-40. PubMed ID: 11848443
[TBL] [Abstract][Full Text] [Related]
9. Specific inhibition of Egr-1 prevents mesangial cell hypercellularity in experimental nephritis.
Carl M; Akagi Y; Weidner S; Isaka Y; Imai E; Rupprecht HD
Kidney Int; 2003 Apr; 63(4):1302-12. PubMed ID: 12631347
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional repression of human insulin-like growth factor-II P4 promoter by Wilms' tumor suppressor WT1.
Lee YI; Kim SJ
DNA Cell Biol; 1996 Feb; 15(2):99-104. PubMed ID: 8634146
[TBL] [Abstract][Full Text] [Related]
11. Effects of Denys-Drash syndrome point mutations on the DNA binding activity of the Wilms' tumor suppressor protein WT1.
Borel F; Barilla KC; Hamilton TB; Iskandar M; Romaniuk PJ
Biochemistry; 1996 Sep; 35(37):12070-6. PubMed ID: 8810912
[TBL] [Abstract][Full Text] [Related]
12. Expression of the transcriptional regulator Egr-1 in experimental glomerulonephritis: requirement for mesangial cell proliferation.
Rupprecht HD; Hoffer G; de Heer E; Sterzel RB; Faller G; Schoecklmann HO
Kidney Int; 1997 Mar; 51(3):694-702. PubMed ID: 9067901
[TBL] [Abstract][Full Text] [Related]
13. Osteoclast differentiation is associated with transient upregulation of cyclin-dependent kinase inhibitors p21(WAF1/CIP1) and p27(KIP1).
Okahashi N; Murase Y; Koseki T; Sato T; Yamato K; Nishihara T
J Cell Biochem; 2001; 80(3):339-45. PubMed ID: 11135363
[TBL] [Abstract][Full Text] [Related]
14. Differential regulation of the Wilms' tumor gene, WT1, during differentiation of embryonal carcinoma and embryonic stem cells.
Scharnhorst V; Kranenburg O; van der Eb AJ; Jochemsen AG
Cell Growth Differ; 1997 Feb; 8(2):133-43. PubMed ID: 9040935
[TBL] [Abstract][Full Text] [Related]
15. c-fos antisense DNA inhibits proliferation of osteoclast progenitors in osteoclast development but not macrophage differentiation in vitro.
Udagawa N; Chan J; Wada S; Findlay DM; Hamilton JA; Martin TJ
Bone; 1996 Jun; 18(6):511-6. PubMed ID: 8805990
[TBL] [Abstract][Full Text] [Related]
16. Effects of phosphodiester and phosphorothioate antisense oligodeoxynucleotides on cell lines which overexpress c-myc: implications for the treatment of Burkitt's lymphoma.
Williams SA; Gillan ER; Knoppel E; Buzby JS; Suen Y; Cairo MS
Ann Oncol; 1997; 8 Suppl 1():25-30. PubMed ID: 9187425
[TBL] [Abstract][Full Text] [Related]
17. Transcription factor Egr-1 regulates glomerular mesangial cell proliferation.
Hofer G; Grimmer C; Sukhatme VP; Sterzel RB; Rupprecht HD
J Biol Chem; 1996 Nov; 271(45):28306-10. PubMed ID: 8910451
[TBL] [Abstract][Full Text] [Related]
18. A WT1 antisense oligonucleotide inhibits proliferation and induces apoptosis in myeloid leukaemia cell lines.
Algar EM; Khromykh T; Smith SI; Blackburn DM; Bryson GJ; Smith PJ
Oncogene; 1996 Mar; 12(5):1005-14. PubMed ID: 8649791
[TBL] [Abstract][Full Text] [Related]
19. Differential contribution of osteoclast- and osteoblast-lineage cells to CpG-oligodeoxynucleotide (CpG-ODN) modulation of osteoclastogenesis.
Amcheslavsky A; Hemmi H; Akira S; Bar-Shavit Z
J Bone Miner Res; 2005 Sep; 20(9):1692-9. PubMed ID: 16059640
[TBL] [Abstract][Full Text] [Related]
20. Early growth response-1 is involved in foam cell formation and is upregulated by the TLR9-MyD88-ERK1/2 pathway.
Kim JS; Park DW; Lee HK; Kim JR; Baek SH
Biochem Biophys Res Commun; 2009 Dec; 390(2):196-200. PubMed ID: 19737531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
